Irritable bowel syndrome Trials in New York, United States
Conditions / Irritable bowel syndrome / New York, United States
Irritable bowel syndrome has been the subject of sustained clinical investigation across multiple research sites.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01257477 | LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) | COMPLETED | — |
| NCT01494233 | A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome | COMPLETED | PHASE2 |
| NCT01130272 | Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea | COMPLETED | PHASE2 |
| NCT00454688 | Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome | COMPLETED | PHASE2 |
| NCT00486876 | A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome | COMPLETED | PHASE2 |
| NCT01553591 | Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) | COMPLETED | PHASE3 |
| NCT05573685 | Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training | COMPLETED | NA |
| NCT01553747 | Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) | COMPLETED | PHASE3 |
| NCT02706483 | Long Term Safety Study of Plecanatide | COMPLETED | PHASE3 |
| NCT03143517 | Fecal Calprotectin Collection Protocol | COMPLETED | — |